GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Impact BioMedical Inc (AMEX:IBO) » Definitions » Inventories, Raw Materials & Components

IBO (Impact BioMedical) Inventories, Raw Materials & Components : $0.00 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Impact BioMedical Inventories, Raw Materials & Components?

Impact BioMedical's inventories, raw materials & components for the quarter that ended in Dec. 2024 was $0.00 Mil.


Impact BioMedical Inventories, Raw Materials & Components Historical Data

The historical data trend for Impact BioMedical's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Impact BioMedical Inventories, Raw Materials & Components Chart

Impact BioMedical Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Raw Materials & Components
Get a 7-Day Free Trial - - - - -

Impact BioMedical Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Impact BioMedical Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Impact BioMedical Business Description

Industry
Traded in Other Exchanges
N/A
Address
275 Wiregrass Parkway, West Henrietta, NY, USA, 14586
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The Company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza.

Impact BioMedical Headlines